KaloBios Pharmaceuticals Inc., the small drug company caught in the glare of publicity surrounding Martin Shkreli, has reached a deal that limits the price-hiking former executive’s role in its future.
from WSJ.com: US Business http://ift.tt/1tpeNqI
via IFTTT
No comments:
Post a Comment